{"id":"NCT02221869","sponsor":"Jazz Pharmaceuticals","briefTitle":"A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-01","primaryCompletion":"2017-02","completion":"2019-01-25","firstPosted":"2014-08-21","resultsPosted":"2019-04-30","lastUpdate":"2019-04-30"},"enrollment":106,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Narcolepsy With Cataplexy"],"interventions":[{"type":"DRUG","name":"Xyrem","otherNames":[]}],"arms":[{"label":"Xyrem","type":"EXPERIMENTAL"},{"label":"Xyrem Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to assess the efficacy and safety of Xyrem in pediatrics subjects with narcolepsy that includes cataplexy.","primaryOutcome":{"measure":"Change in Weekly Number of Cataplexy Attacks","timeFrame":"From the end of the Stable Dose Period to the end of the Double-blind Treatment Period (2 weeks)","effectByArm":[{"arm":"Xyrem","deltaMin":0.27,"sd":null},{"arm":"Xyrem Placebo","deltaMin":12.71,"sd":null}],"pValues":[]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":20,"countries":["United States","France","Italy","Netherlands"]},"refs":{"pmids":["37942930","35689598","34920345","30169321"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":104},"commonTop":["Enuresis","Nausea","Vomiting","Headache","Weight decreased"]}}